GSA Capital Partners LLP Acquires Shares of 86,412 Alignment Healthcare, Inc. $ALHC

GSA Capital Partners LLP acquired a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 86,412 shares of the company’s stock, valued at approximately $2,057,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of America Corp DE grew its stake in Alignment Healthcare by 156.5% during the 1st quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock worth $56,660,000 after buying an additional 1,961,778 shares during the last quarter. 1492 Capital Management LLC lifted its stake in Alignment Healthcare by 61.8% in the fourth quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock valued at $6,416,000 after buying an additional 124,143 shares during the last quarter. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Alignment Healthcare in the fourth quarter valued at approximately $39,500,000. William Blair Investment Management LLC boosted its holdings in shares of Alignment Healthcare by 8.7% in the fourth quarter. William Blair Investment Management LLC now owns 2,305,255 shares of the company’s stock valued at $45,529,000 after acquiring an additional 185,303 shares during the period. Finally, Simplify Asset Management Inc. boosted its holdings in shares of Alignment Healthcare by 92.0% in the fourth quarter. Simplify Asset Management Inc. now owns 262,880 shares of the company’s stock valued at $5,192,000 after acquiring an additional 125,946 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $19.55, for a total value of $586,500.00. Following the transaction, the president directly owned 947,313 shares of the company’s stock, valued at approximately $18,519,969.15. The trade was a 3.07% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John E. Kao sold 298,000 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $13.88, for a total transaction of $4,136,240.00. Following the transaction, the chief executive officer owned 790,766 shares of the company’s stock, valued at approximately $10,975,832.08. The trade was a 27.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,009,951 shares of company stock worth $18,597,287 over the last quarter. 5.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ALHC. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. TD Cowen reiterated a “buy” rating on shares of Alignment Healthcare in a research note on Monday, August 3rd. Raymond James Financial downgraded shares of Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the stock from $22.00 to $19.00 in a research report on Monday, August 3rd. JPMorgan Chase & Co. dropped their price objective on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 4th. Finally, Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Seven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $23.60.

Alignment Healthcare Stock Up 3.7%

Alignment Healthcare stock opened at $13.96 on Friday. The stock has a 50 day moving average of $19.43 and a two-hundred day moving average of $19.15. Alignment Healthcare, Inc. has a twelve month low of $13.05 and a twelve month high of $25.12. The stock has a market capitalization of $2.90 billion, a price-to-earnings ratio of 73.48 and a beta of 1.10. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The business had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same quarter in the previous year, the company posted $0.07 earnings per share. The company’s revenue for the quarter was up 31.6% compared to the same quarter last year. As a group, research analysts expect that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current year.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.